SCHEMBL4148649

SCHEMBL4148649

CSc1ccc(-c2cnc(NCCc3ccncc3)cn2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR Q13258 1/20 0.39
FYN P06241 3/20 0.39
MKNK1 Q9BUB5 3/20 0.38
MKNK2 Q9HBH9 3/20 0.38
PCSK9 Q8NBP7 2/20 0.38
CNR2 P34972 1/20 0.37
THRB P10828 2/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
CLK1 P49759 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36
ACP1 P24666 1/20 0.36
HTT P42858 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4148108 0.83 FYN (0.41) PTGDRFYNMKNK1MKNK2KDM4E
SCHEMBL4139805 0.77 FYN (0.56) PTGDRFYNCNR2KDM4EALDH1A1
SCHEMBL4139796 0.77 CYP1A2 (0.47) PTGDRMKNK1MKNK2KDM4EALDH1A1
SCHEMBL4139867 0.77 TPH1 (0.45) PTGDRMKNK1MKNK2KDM4EACP1
SCHEMBL4147501 0.75 CCNT1 (0.46) PTGDRFYNMKNK1MKNK2CCNT1
SCHEMBL4160480 0.72 PDGFRB (0.50) MKNK1MKNK2CNR2KDM4EALDH1A1
SCHEMBL4156800 0.72 NAMPT (0.57) PTGDRKDM4EALDH1A1MAPTNPC1
SCHEMBL4152322 0.71 MKNK1 (0.43) FYNMKNK1MKNK2HTTCYP1A2
SCHEMBL31065714 0.69 ALDH1A1 (0.42) KDM4EALDH1A1MAPTMAPK1HSD17B10
SCHEMBL8361629 0.69 LOXL2 (0.46) KDM4EALDH1A1HPGDHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163515-A1 Compounds Which Bind to the Active Site of Protein Kinase Enzymes BIOFOCUS DISCOVERY LTD. 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163515-A1 Compounds Which Bind to the Active Site of Protein Kinase Enzymes ROCK1, ROCK2, CIT PTGDR 1188/4885FYN 114/4885MKNK1 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.